Tickers featured: ABGX, AGIX, AMGN, AVGN, AZN, BGEN, CATG, CEGE, CHIR, CRGN, DNA,
GNVC, HGSI, IDPH, IMCL, INCY, MEDI, MLNM, ONXX, OSIP, RHHVF, TLRK, VICL.
Tickers featured: ABGX, ALKS, AMGN, AZN, BGEN, BMY, CVTX, DNA, ENZN, GILD,
GNVC, IDPH, ILXO, IMCLE, ISIS, JNJ, LJPC, MEDI, MLNM, NBIX, NPS, NPSP, NVS, OSIP, PFE, SCIO, SRA, TGEN, VICL, VRTX.
25 January 2010 - US-based biopharmaceutical company GenVec Inc (NASDAQ:
GNVC) announced today that data from the company's trial in esophageal cancer were presented at the American Society of Clinical Oncology's 2010 Gastrointestinal Cancer Symposium in Orlando, Florida on 22 January 2010.
Tickers featured: ABGX, ABT, ALLP, AMGN, AMLN, AVE, AVGN, BGEN, BMY, CEGE, CRA, DNA, DOW, DVSA, FBR, GILD,
GNVC, HGSI, IDBE, IDPH, IMCL, IMNX, ISIS, JNJ, KERX, LLY, MEDI, MLNM, NWBT, ONXX, SCLN, SRA, SYT, TELK, TRMS, TTP, VICL.
Tickers featured: ALKS, ALXN, AMGN, APL, AZN, BGEN, BPUR, CELG, CHIR, CVTX, DNA, DYAX, GENZ, GILD,
GNVC, HGSI, IDPH, IMCL, IMNX, LEXG, LSBC, MAXM, MDCO, MEDI, NVS, OSIP, REGN, SGEN, SRA, TLRK, TNF, VPHM, VRTX.